From: Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
Model inputs | PICT | HBT | VCT | Distributiona | Alpha-Betab | Source |
---|---|---|---|---|---|---|
Probabilitiesc | ||||||
 Individual reached | – | 0.752 | – | β | 8192–2705 (HBT) | [12] |
 Not known HIV-positive/not pregnant | – | 0.822 | – | β | 6736–1456 (HBT) | [12] |
 Gave consentd | – | 0.760 | – | β | 5116–1620 (HBT) | [12] |
 HIV test positive | 0.312 | 0.072 | 0.119 | β | 1046–2305 (PICT); 369–4747 (HBT); 909–6718 (VCT) | [12] |
 Enrolled in study | 0.404 | – | 0.363 | β | 423–623 (PICT); 330–579 (VCT) |  |
 Enrolled in care | 0.908 | 0.355 | 0.985 | β | 384–39 (PICT); 131–238 (HBT); 325–5 (VCT) | [12] |
 Attended 1st consultation | 0.799 | 0.901 | 0.911 | β | 307–77 (PICT); 118–13 (HBT); 296–29 (VCT) | [12] |
 Linked to care | 0.642 | 0.746 | 0.693 | β | 197–110 (PICT); 88–30 (HBT); 205–91 (VCT) | [12] |
Costse | ||||||
 Average cost per test (SD), US$ | 7.14 (1.30) | 11.07 (3.82) | 7.79 (1.30) | γ | 30.3–0.235 (PICT); 8.39–1.32 (HBT); 36.1–0.216 (VCT) | Table 2 |